Addressing a crucial need, our device CLARA offers a
non-invasive alternative treatment for Cutaneous Leishmaniasis
What is cutaneous Leishmaniasis?
Cutaneous Leishmaniasis is a neglected tropical disease that affects millions worldwide. This condition, caused by parasites transmitted through sandfly bites, results in painful skin ulcers and can lead to severe scarring and disability. Despite its widespread impact, it remains under-researched and overlooked in the global health landscape.
The Risks of Traditional Treatments
Drug injections have been the frontline treatment for Cutaneous Leishmaniasis (CL). However, these treatments can present serious risks. They're not only invasive but can cause severe side effects, including muscle pain, heart complications, and potential damage to the liver or kidneys. Furthermore, the considerable pain associated with the injections and the lengthy treatment duration often deter patients from pursuing this treatment option.
Unseen Scars: The Stigma of CL
Affecting millions in rural and poverty-stricken areas, this neglected tropical disease often results in visible lesions, leading to stigma and ostracization. People affected by CL carry not just the physical pain but also the burden of social exclusion, influencing their self-esteem and their place within their communities.
We are supported by
.png){kind=logo}
